With any screening process (either carried out at a laboratory or via a “Point of Care” drug test device/kit) you will inevitably get “false positives”, “false negatives”, “real negatives” and “real positives”. “False negatives” are rarely challenged by the sample donor – e.g. why would an employee argue that they were negative for drugs? All “POC positive” results (also known as “non-negative” and/or “presumed positive” screen results) should be confirmed via a UKAS accredited laboratory confirmatory analysis – such as LCMS, GCMS or similar. This confirmation result, together with a report from a Medical Review Officer when applicable, is considered as the definitive result.
Charity Alcohol Change UK have announced Alcohol Awareness Week (AAW) 2019 will take place from 11-17 November. Are you / your workplace doing anything to support and promote Alcohol Awareness Week?
Pregabalin and Gabapentin to be controlled as class C drugs from April 2019 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019, the government announced on 15 October 2018.The move comes after experts highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.
Official figures show that drug deaths have risen sharply in England and Wales, reaching record numbers last year. A total of 4,359 people died due to drug poisoning last year, this includes accidental overdoses and suicides from medicinal drugs, as well as illicit drug use.